Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Determinants of COVID-19 vaccine-induced myocarditis
Jessica Rose, Nicolas Hulscher, Peter A. McCullough
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 12
The mRNA-LNP vaccines – the good, the bad and the ugly?
Botond Z. Igyártó, Zhen Qin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 7
Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination
Nicolas Hulscher, Brian C. Procter, Cade Wynn, et al.
Cureus (2023)
Open Access | Times Cited: 15
Efficacy of Vitamin D Replacement Therapy on 28 Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After COVID-19 Vaccination
Shohta Kodama, Nafuko Konishi, Yuriko Hirai, et al.
Nutrition (2025) Vol. 134, pp. 112718-112718
Open Access
Risk stratification for future cardiac arrest after COVID-19 vaccination
Peter A McCullough, Nicolas Hulscher
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Closed Access
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
Miki Gibo, Seiji Kojima, Akinori Fujisawa, et al.
Cureus (2024)
Open Access | Times Cited: 4
Diagnostik und Therapie bei Post-COVID-19 und Post-Vaccination-Syndrom
Harald Matthes
Deutsche Zeitschrift für Akupunktur (2025)
Open Access
mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
Mingyue Pan, Weiling Cao, Jingbo Zhai, et al.
International Journal of Biological Macromolecules (2025), pp. 143134-143134
Closed Access
Apparent Cytotoxicity and Intrinsic Cytotoxicity of Lipid Nanomaterials Contained in a COVID-19 mRNA Vaccine
Gabriele Segalla
International Journal of Vaccine Theory Practice and Research (2023) Vol. 3, Iss. 1, pp. 957-972
Open Access | Times Cited: 10
Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Matthew Halma, Paul E. Marik, Yusuf M. Saleeby
Endocrine and Metabolic Science (2024) Vol. 14, pp. 100163-100163
Open Access | Times Cited: 3
Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington
Nicolas Hulscher, Michael J. Cook, Raphael B. Stricker, et al.
(2024)
Open Access | Times Cited: 3
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook
Arneaux Kruger, David Joffe, Graham Lloyd‐Jones, et al.
Seminars in Thrombosis and Hemostasis (2024)
Open Access | Times Cited: 3
Delayed Fatal Pulmonary Hemorrhage Following COVID-19 Vaccination: Case Report, Batch Analysis, And Proposed Autopsy Checklist
Nicolas Hulscher, Peter A. McCullough
(2024)
Open Access | Times Cited: 2
COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment
Mina Kelleni
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination–Associated Thrombotic Microangiopathy
Pujan Moradiya, Priyanka Khandelwal, Rupesh Raina, et al.
Kidney International Reports (2024) Vol. 9, Iss. 11, pp. 3134-3144
Open Access | Times Cited: 2
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
Effects of spike proteins on angiotensin converting enzyme 2 (ACE2)
Jennyfer Bejoy, Charlye I. Williams, Hattie J. Cole, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 748, pp. 109769-109769
Open Access | Times Cited: 5
Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
Jun Ueda, Hideyuki Motohashi, Yuriko Hirai, et al.
(2024)
Open Access | Times Cited: 1
1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit
Jozef Nahálka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4440-4440
Open Access | Times Cited: 1
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses
David Scheim, Peter Parry, David J. Rabbolini, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 647-647
Open Access | Times Cited: 1
Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific Measures
Jun Ueda, Hideyuki Motohashi, Yuriko Hirai, et al.
(2024)
Open Access | Times Cited: 1
Strategic Deactivation of mRNA COVID-19 Vaccines: New Applications for RIBOTACs and siRNA Therapy
Nicolas Hulscher, Peter A. McCullough, Diane Marotta
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top